Understanding non-compliance to colorectal cancer screening: A case control study, nested in a randomised trial [ISRCTN83029072]

BMC Public Health

Volumn 5, Issue , 2005, Pages

  Rossi, Paolo Giorgi ^a   Federici, Antonio ^a   Bartolozzi, Francesco ^b   Farchi, Sara ^a   Borgia, Piero ^a   Guasticchi, Gabriella ^a  

^a Agency for Public Health   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; DOCTOR PATIENT RELATION; FEAR; GEOGRAPHY; HEALTH CARE DELIVERY; MASS SCREENING; MIDDLE AGED; PATIENT ATTITUDE; PSYCHOLOGY; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; TREATMENT REFUSAL; UTILIZATION;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEAR; FEMALE; GEOGRAPHY; HEALTH SERVICES ACCESSIBILITY; HOSPITAL-PATIENT RELATIONS; HUMANS; ITALY; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; TREATMENT REFUSAL;

EID: 31544460397     PISSN: 14712458     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-5-139     Document Type: Article

References (27)

1. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C: A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 1998, 317:559-565.
2. Box V, Nichols S, Lallemand RC, Pearson P, Vakil PA: Haemoccult compliance rates and reasons for non-compliance. Public Health 1984, 98:16-25.
3. Farrands PA, Hardcastle JD, Chamberlain J, Moss S: Factors affecting compliance with screening for colorectal cancer. Community Med 1984, 6:12-9.
4. Blalock SJ, DeVellis BM, Sandler RS: Participation in fecal occult blood screening: a critical review. Prev Med 1987, 16:9-18.
5. Vernon SW: Participation in Colorectal Cancer Screening: a Review. J Nat Cancer Inst 1997, 89:1406-1422.
6. Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J: The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess 2000, 4(14):i-vii. 1-133
7. Schoen RE: The case for population-based screening for colorectal cancer. Nat Rev Cancer 2002, 2:65-70.
8. Rosenstock IM: Patients' compliance with health regimens. JAMA 1975, 234:402-403.
9. Giorgi Rossi P, Federici A, Bartolozzi F, Farchi S, Borgia P, Guastcchi G: Trying to improve the compliance to colorectal cancer screening: a complex study design for a complex planning question. Cont Clin Trial 2005, 26:323-330.
10. Federici A, Giorgi Rossi P, Bartolozzi F, Farchi S, Borgia P, Guastcchi G: Survey on colorectal cancer screening knowledge, attitudes and practices of general practice physicians in Lazio, Italy. Prev Med 2005, 41:30-35.
11. Federici A, Giorgi Rossi P, Borgia P, Bartolozzi F, Farchi S, Gausticchi G: The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programs: a cluster randomised controlled trial. J Med Screen 2005, 12:83-88.
12. Federici A, Giorgi Rossi P, Bartolozzi F, Farchi S, Borgia P, Guasticchi G: The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial. Cancer Causes and Control 2006, 17:45-52.
13. Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, Ferraris R, Gasperoni S, Penna A, Risio M, Rossini FP, Sciallero S, Zappa M, Atkin WS: SCORE Working Group - Italy. Baseline findings of the Italian multicenter randomized controlled trial of "onceonly sigmoidoscopy" - SCORE. J Natl Cancer Inst 2002, 94:1763-72.
14. Hosmer DW Jr, Lemeshow S: Applied Logistic Regression. 2nd edition. New York: John Wiley & Sons; 2001.
15. Stata Corporation: Stata statistical software: release 7.0. CollegeStation, TX. Stata Corporation; 2001.
16. Schoenman JA, Berk ML, Feldmann JJ, Singer A: Impact of differential response rate on the quality of data collected in the CTS physician survey. Eval Health Prof 2003, 26:23-42.
17. King J, Fairbrother G, Thompson C, Morris DL: Colorectal cancer screening: optimal compliance with postal faecal occult blood test. Aust N Z J Surg 1992, 62:714-9.
18. Ornstein SM, Musham C, Reid A, Jenkins RG, Zemp LD, Garr DR: Barriers to adherence to preventive services reminder letters: the patient's perspective. J Fam Pract 1993, 36:195-200.
19. Brunton M, Thomas DR: Privacy or life: how do women find out about screening mammography services? N Z Med J 2002, 115:U168.
20. Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ: Patterns and predictors of colorectal cancer test use in theadult U.S. population. Cancer 2004, 100:2093-103.
21. American Gastroenterological Association: Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997, 112:594-642.
22. Macrae FA, Hill DJ, St John DJ, Ambikapathy A, Garner JF: Predicting colon cancer screening behavior from health beliefs. Prev Med 1984, 13:115-26.
23. Spector MH, Applegate WB, Olmstead SJ, DiVasto PV, Skipper B: Assessment of attitudes toward mass screening for colorectal cancer and polyps. Prev Med 1981, 10:105-9.
24. Bulliard JL, de Landtsheer JP, Levi F: Profile of women not attending in the Swiss Mammography Screening Pilot Programme. Breast 2004, 13:284-9.
25. Kreher NE, Hickner JM, Ruffin MT 4th, Lin CS: Effect of distance and travel time on rural women's compliance with screening mammography: an UPRNet study. Upper Peninsula Research Network. J Fam Pract 1995, 40:143-7.
26. Andreu Vaillo Y, Galdon Garrido MJ, Dura Ferrandis E, Carretero Gomez S, Tuells Hernandez J: [Age, health beliefs, and attendance to a mammography screening program in the community of Valencia]. Rev Esp Salud Publica 2004, 78:65-82.
27. Nichols S, Koch E, Lallemand RC, Heald RJ, Izzard L, Machin D, Mullee MA: Randomised trial of compliance with screening for colorectal cancer. BMJ 1986, 293:107-10.